about
ADAMTS13 substrate recognition of von Willebrand factor A2 domainElucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunitiesThe protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activityAutoantibodies to thrombin directed against both of its cryptic exosites.A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malariaActivated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.Risk factors for pregnancy-associated venous thromboembolism: a review.Binding of calcium to anticoagulant protein S: role of the fourth EGF moduleThe helminth T2 RNase ω1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism.Does antithrombotic therapy improve survival in cancer patients?The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling.A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective PAR1 signaling.Engineering activated protein C to maximize therapeutic efficacy.Emerging roles for hemostatic dysfunction in malaria pathogenesis.N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation.Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex.Neonatal brain injury and systemic inflammation: modulation by activated protein C ex vivo.Multifunctional specificity of the protein C/activated protein C Gla domain.Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13.Platelet factor 4 impairs the anticoagulant activity of activated protein C.Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis.Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study.Galectin-1 and Galectin-3 Constitute Novel-Binding Partners for Factor VIII.The Immunoregulatory Activities of Activated Protein C in Inflammatory Disease.Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.A novel role for the macrophage galactose-type lectin (MGL) receptor in mediating von Willebrand factor clearance.Emerging Roles for von Willebrand Factor in Cancer Cell Biology.Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria.von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearancein vivoProtamine sulfate down-regulates thrombin generation by inhibiting factor V activationConcentration-dependent roles for heparin in modifying liopolysaccharide-induced activation of mononuclear cells in whole bloodExtrahemostatic Functions of Platelets and Coagulation FactorsMicrobiome influences von Willebrand factorMolecular basis of protease-activated receptor 1 signaling diversityGlutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 DeglutathionylationAdvances in understanding the molecular mechanisms of venous thrombosisAdvances in understanding the molecular mechanisms that maintain normal haemostasis
P50
Q24338203-3DDD9189-748B-4E60-8288-807F9AA8D37AQ26851855-92705F0B-7206-4358-A9DB-04B6C5261BB7Q28306338-A965DCF0-F594-4DF0-BFC4-77CCDBB6CC97Q33231591-05CFA36B-DC7A-496C-8F24-CD4A9FFAC515Q33427139-751A5105-3C7F-4748-9297-23C6A98DD85FQ34488999-A2AB0C08-0DBA-46B6-887E-662CF3CE6602Q35066197-68A45E3A-C327-41CD-B908-8A8EA0CEBC27Q36459370-19ADB78A-196D-4D74-8E93-44650FAF5AE4Q37151880-634DB22A-5642-4B42-A0C0-E737428E6B12Q37338570-D4B0BFBB-9CD2-4C4C-B09F-45181051A4ECQ37942050-7D3839CD-F32A-42F1-B335-507A174DBA2DQ38611757-C3EBCE10-8FC2-43B9-B3CD-35D6CD51C740Q38628912-88BF8708-3706-4298-A9EE-0E8A49FDD943Q38724769-66742E09-1F21-424A-8243-5D31B2904111Q38750537-A16F75DD-608C-4250-A85D-6F629DFE4C45Q39299024-DA462B79-D15D-4485-A0B4-B04CC9D5BEE4Q40474485-40B34739-976A-446F-8F64-DD6DA799C633Q40579813-48FD14EB-6923-4CD4-A426-3B6A082B9870Q41746195-F6A1B80D-80E8-4427-9ADE-68D7C09A50F5Q42692755-A638ED8D-A72C-4036-8A42-E50055A7755FQ43228846-E59052C2-B1C8-4396-90D9-F80AAFFF6BFAQ43667908-B315D7AA-4E30-4F39-92C3-A898FFD9A105Q43701770-6CA7481E-7866-4BAE-8307-C7DC9D3C8FD7Q44563073-D85D940D-CA44-474A-ABBE-73720F1FDD4CQ45884365-77B9FD69-FC49-4300-B874-7FEA90FBAA5CQ47302257-BE753700-51CC-4A81-BD12-31E5E27ECE65Q47793791-F43BD773-E484-4050-ACD4-87BFA262F653Q48124029-9AFC25B5-26EC-47A0-B671-39F8D5460BBBQ49547979-09602552-ABC9-47F0-B2EB-09067260E4ADQ49807407-9C768CCA-68B8-441E-A6B6-40FB44F36FB9Q55223220-3A0448B8-687E-48A4-A60F-D82C21704214Q60034580-5A992D4C-A3F1-4462-B485-113974E7E1F7Q60034598-9006C21A-6553-4486-8E4C-BD96F8D7C425Q60034601-814E8834-0317-4856-A22A-674CEC449A4BQ87852352-F134071B-884A-4825-9D99-4DC903A459E4Q88621210-347A2E1D-CAA2-4F55-9799-12E361E2928AQ90251583-CED4A949-ED87-463A-B238-2AA2AB8E8347Q90438637-B8EBD0F3-6FB0-415E-B3EE-3EF4797B009AQ92588363-F4236336-02F3-4800-8A8B-D673DC3985C0Q92668404-9281425D-BEF9-4822-A822-BC74A56CF891
P50
description
researcher ORCID ID = 0000-0003-0108-4077
@en
wetenschapper
@nl
name
R Preston
@ast
R Preston
@en
R Preston
@es
R Preston
@nl
type
label
R Preston
@ast
R Preston
@en
R Preston
@es
R Preston
@nl
prefLabel
R Preston
@ast
R Preston
@en
R Preston
@es
R Preston
@nl
P106
P1153
12774078500
P31
P496
0000-0003-0108-4077